SUPERNUS PHARMACEUTICALS INCSUPERNUS PHARMACEUTICALS INCSUPERNUS PHARMACEUTICALS INC

SUPERNUS PHARMACEUTICALS INC

No trades
See on Supercharts

S49 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

S49 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company